/
PRQR
$1.85-$0.01 (-0.54%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$262.5M
141M shares
52-week range
$1.33 – $3.10
29% from low
Exchange
NASDAQ
CS
Change$-3.92
ProQR Therapeutics N.V. Ordinary Shares
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
www.proqr.com- Employees
- 187
- IPO / List date
- Sep 18, 2014
Held by traders on TradeandTell
No one on the platform currently holds PRQR.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PRQR as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PRQR yet.
